Rubicon Research files for IPO with SEBI, Targets ₹10,850 Million to drive growth and innovation Read more
Viking Therapeutics’ obesity drug could become direct competitor to Eli Lilly’s tirzepatide: GlobalData Read more
Vector Consulting Group reveals strategies for pharma firms to boost agility and cost efficiency in the US market Read more
Phase III post-marketing commitment study data paves way for usage of Paratek’s Nuzyra in other indications: GlobalData Read more